Comparison of nitrogen bioaccessibility from salmon and whey protein hydrolysates using a human gastrointestinal model (TIM-1)

Functional Foods in Health and Disease

Volumn 4, Issue 5, 2014, Pages 222-231

  Framroze, Bomi ^a   Savard, Patricia ^b   Gagnon, Diane ^b   Richard, Véronique ^b   Gauthier, Sylvie F ^b  

^a Hofseth Biocare ASA   (Norway)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Nitrogen bioaccessibility; Salmon protein hydrolysate; TIM 1; Whey protein

Indexed keywords

EID: 84975467739     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v4i5.10     Document Type: Article

References (23)

1. Minekus M, Marteau P, Havenaar R. A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA-Altern Lab Anim 1995; 197-209.
2. Fernández-Garcia E, Carvajal-Lérida I, Pérez-Gálvez A. In vitro bioaccessibility assessment as a prediction tool of nutritional efficiency. Nutr Res 2009; 29: 751-760.
3. Havenaar R. The model selection tool. Dairy Ind Int 1999; 64(6): 33-36.
4. Zeijdner EE, Mohede ICM. Latest tool for screening new clinical foods. A dynamic, computer-controlled model of the human gastrointestinal tract is the most up-to-date technology for testing new foods. New World Health 1999; 105: 1-12.
5. Dickinson PA, Abu Rmaileh R, Ashworth L, Baker RA, Burke WM, Patterson CM, Stainforth N, Yasin M. An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence of poorly soluble drugs. AAPS J 2012; 14: 196-205.
6. Salovaara S, Alminger ML, Eklund-Jonsson C. Prolonged transit time through the stomach and small intestine improves iron dialyzability and uptake in vitro. J Agric Food Chem 2003; 51: 5131-5136.
7. Larsson M, Minekus M, Havenaar R. Estimation of the bioavailability of iron and phosphorus in cereals using a dynamic gastrointestinal model. J Sci Food Agric 1997; 74: 99-106.
8. Verwei M, Arkbage K, Havenaar R, Van den Berg H, Witthöft C, Schaafsma G. Folic acid and 5-methyl-tetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. J Nutr 2003; 133: 2377-2383.
9. Courraud J, Berger J, Cristol J-P, Avallone S. Stability and bioaccessibility of different forms or carotenoids and vitamin A during in vitro digestion. Food Chem 2013; 136: 871-877.
10. Venema K, Dohnalek MH. Digestibility and availability of nitrogen for whey protein hydrolysate products assessed using a dynamic in vitro gastrointestinal model. J Allergy Clin Immunol 2006; 117: 304.
11. Picariello G, Mamone G, Nitride C, Addeo F, Ferranti P. Protein digestomics: Integrated platforms to study food-protein digestion and derived functional and active peptides. TrAC Trends in Analytical Chemistry 2013; 52: 120-134.
12. Butts CA, Monro JA, Moughan PJ. In vitro determination of dietary protein and amino acid digestibility for humans. Br J Nutr 2012; 108(S2): 282-287.
13. Nabil S, Gauthier SF, Drouin R, Poubelle PE, Pouliot Y. In vitro digestion of proteins and growth factors in a bovine whey protein extract as determined using a computer-controlled dynamic gastrointestinal system (TIM-1). Food Dig 2011; 2: 13-22.
14. Chen L, Hébrard G, Beyssac E, Denis S, Subirade M. In vitro study of the release properties of soy-zein protein microspheres with a dynamic artificial digestive system. J Agric Food Chem 2010; 58: 9861-9867.
15. Blanquet-Diot S, Soufi M, Rambeau M, Rock E, Alric M. Digestive stability of xanthophylls exceeds that of carotenes as studied in a dynamic in vitro gastrointestinal system. 2009; 139: 876-883.
16. Lila MA, Ribnicky DM, Rojo LE, Rojas-Silva, P, Oren A, Havenaar R, Janle EM, Raskin I, Yousef GG, Grace MH. Complementary approaches to gauge the bioavailability and distribution of ingested berry polyphenolics. 2012; 60: 5763-5771.
17. Blanquet S, Zeijdner E, Beyssac E, Meunier J-P, Denis S, Havenaar R, Alric M. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res 2004; 21: 585-591.
18. Souliman S, Blanquet S, Beyssac E, Cardot J-M. A level A in vitro/in vivo correlation in fasted and fed states using different methods: Applied to solid immediate release oral dosage form. Eur J Pharm Sci 2006; 27: 72-79.
19. Report on Molecular weight and peptide distribution in salmon protein hydrolysate. Green Earth Industries Reports 2008; 1-9.
20. Gauthier SF, Pouliot Y. Functional and biological properties of peptides obtained by enzymatic hydrolysis of whey proteins. J Dairy Sci 2003; 86: E78-E87.
21. Liu X, Jiang D, Peterson DG. Identification of bitter peptides in whey protein hydrolysate. J Agric Food Chem 2013; dx.doi.org/10.1021/jf4019728.
22. Leksrisompong P, Gerard P, Lopetcharat K, Drake M. Bitter taste inhibiting agents for whey protein hydrolysate and whey protein hydrolysate beverages. J Food Sci 2012; 77: S282-S287.
23. Dumas JBA. Precedes de l'analyse organique. Ann Chim Phys 1831; 47: 198-205.